Three hospital groups and several individual hospitals have filed suit against HHS to prevent billions in cuts to the 340B drug discount program.
Hospitals and healthcare trade groups mostly came out in support of Alex Azar, President Trump's pick to replace Tom Price as head of HHS.
Some healthcare industry experts are cautiously optimistic about the Trump administration's new approach to value-based care.
There are several reasons why accountable care organizations may generate sluggish savings, according to a new study.
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts for prescription drugs.
With time running out until states exhaust funding for CHIP, a trade group has launched a campaign to prod Congress to act.
The ex-president of Eli Lilly and Co. is President Donald Trump’s choice to replace Tom Price as Health and Human Services secretary.
The Senate version of the GOP tax bill does not include a repeal of the ACA individual mandate, and it's not looking likely to make it into the House…
Two states received millions of dollars’ worth of unallowable bonus payments that are meant to offset the cost of enrolling children in Medicaid.
The experience of one Medicare ACO shows that the model can be adapted to meet the needs of safety-net providers and their unique patient populations.